QuickView for Tusc2;jsessionid=5103DE0FE3A36B1E1736354AED7AEF00;jsessionid=3D06B0817A8C9BE0A3B2D9161930BAF0;jsessionid=7949AB609652746A31DD5ACDE69B73D5 (gene)

Summary
General Info

Body Atlas

Most Correlated Tissues

Skeletal muscle psoas
Cerebellum peduncles
Cingulate cortex
Globus pallidus
Pons

Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

Hypertrophic cardiomyopathy
Rhinitis
Injury of eye region
Age AND/OR growth finding
Interstitial lung disease

Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

benz(a)anthracene
Terazosin
epigallocatechin gallate
oxantel
cefepime

Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

MIR106B
MIR106A
PAICS
PRNP
FXN

Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Explore Curated Studies Results

Literature

Most Relevant Literature

TUSC2 immunogene enhances efficacy of chemo-immuno combination on KRAS/LKB1 mutant NSCLC in humanize…
NEDD4 degrades TUSC2 to promote glioblastoma progression.
Mitochondrial protein Fus1/Tusc2 in premature aging and age-related pathologies: critical roles of c…
The HDAC inhibitor HFY-4A improves TUSC2 transcription to induce immunogenic cell death in breast ca…
Circ-EGFR Functions as an Inhibitory Factor in the Malignant Progression of Glioma by Regulating the…

Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

There were no clinical trials for Tusc2;jsessionid=5103DE0FE3A36B1E1736354AED7AEF00;jsessionid=3D06B0817A8C9BE0A3B2D9161930BAF0;jsessionid=7949AB609652746A31DD5ACDE69B73D5

Explore Clinical Trials Results